ErratumTo: Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-0711
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
ErratumTo: Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial ; volume:8 ; number:1 ; day:16 ; month:2 ; year:2009 ; pages:1 ; date:12.2009
Annals of clinical microbiology and antimicrobials ; 8, Heft 1 (16.2.2009), 1, 12.2009
- Urheber
-
Abdelaal, Amina
El-Ghaffar, Hassan Abd
Zaghloul, Mohammad Hosam Eldeen
El mashad, Noha
Badran, Ehab
Fathy, Amal
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-0711-8-5
- URN
-
urn:nbn:de:101:1-2021082221263325411566
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abdelaal, Amina
- El-Ghaffar, Hassan Abd
- Zaghloul, Mohammad Hosam Eldeen
- El mashad, Noha
- Badran, Ehab
- Fathy, Amal
- SpringerLink (Online service)
Ähnliche Objekte (12)
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosisisolates from Ethiopia
Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Zur Resorption der Antituberkulotika Ethambutol, Rifampicin und Isoniazid bei magenresezierten, tuberkulosekranken Patienten
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
Evaluation of Anyplex™ II MTB/MDR kit’s performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosis
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosisisolates from Ethiopia
Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Zur Resorption der Antituberkulotika Ethambutol, Rifampicin und Isoniazid bei magenresezierten, tuberkulosekranken Patienten
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
Evaluation of Anyplex™ II MTB/MDR kit’s performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosis
Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial
Molecular detection of Mycobacterium tuberculosis sensitivity to rifampicin and isoniazid in South Gondar Zone, northwest Ethiopia
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosisisolates from Ethiopia
Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Zur Resorption der Antituberkulotika Ethambutol, Rifampicin und Isoniazid bei magenresezierten, tuberkulosekranken Patienten
Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
Evaluation of Anyplex™ II MTB/MDR kit’s performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)